Safety of Once- or Twice-Daily Dosing of Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in Patients With Nonvalvular Atrial Fibrillation: A NOAC-TR Study. Biomol Biomed 2018, 18 (2), 185-190. https://doi.org/10.17305/bjbms.2017.2279.